These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38100670)

  • 1. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
    Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
    Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets.
    Loke YH; Chew YL; Janakiraman AK; Lee SK; Uddin ABMH; Goh CF; Kee PE; Ng HS; Ming LC; Liew KB
    Drug Dev Ind Pharm; 2024 Jan; 50(1):36-44. PubMed ID: 38149637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization, optimisation and process robustness of a co-processed mannitol for the development of orally disintegrating tablets.
    Soh JL; Grachet M; Whitlock M; Lukas T
    Pharm Dev Technol; 2013 Feb; 18(1):172-85. PubMed ID: 22582882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets.
    Liew KB; Hii SH; Chew YL; Ming LC; Uddin AH; Sarker ZI
    Int J Pharm Compd; 2022; 26(3):255-263. PubMed ID: 35657749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application.
    Bin LK; Helaluddin ABM; Islam Sarker MZ; Mandal UK; Gaurav A
    Pak J Pharm Sci; 2020 Mar; 33(2):551-559. PubMed ID: 32276897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Texture Analysis Technique in Formulation Development of Lyophilized Orally Disintegrating Tablets Containing Mannitol, Polyvinylpyrrolidone and Amino Acids.
    Hackl E; Ermolina I
    AAPS PharmSciTech; 2019 Jan; 20(2):71. PubMed ID: 30631978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionality of disintegrants with different mechanisms after roll compaction.
    Berkenkemper S; Keizer HL; Lindenberg M; Szepes A; Kleinebudde P
    Int J Pharm; 2020 Jun; 584():119434. PubMed ID: 32439584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of microwave-treated orally disintegrating tablets containing polymeric disintegrant and mannitol.
    Sano S; Iwao Y; Noguchi S; Kimura S; Itai S
    Int J Pharm; 2013 May; 448(1):132-41. PubMed ID: 23524122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Loratadine Orally Disintegrating Tablets by Semi-solid Extrusion 3D Printing.
    Yi S; Xie J; Chen L; Xu F
    Curr Drug Deliv; 2023; 20(6):818-829. PubMed ID: 36221886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract.
    Azman SEN; Abd Razak FS; Kamal WHBW; Zheng GK; Ming LC; Uddin AH; Sarker ZI; Bin LK
    Int J Pharm Compd; 2020; 24(6):509-514. PubMed ID: 33217741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets.
    Azmi NHS; Ming LC; Uddin ABMH; Sarker ZI; Bin LK
    Int J Pharm Compd; 2022; 26(1):80-87. PubMed ID: 35081048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve Paediatric Patient's Compliance.
    Juan C; Gallo L; Gonzalez Vidal N
    AAPS PharmSciTech; 2024 Apr; 25(4):79. PubMed ID: 38589718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet.
    Rahim N; Naqvi SB; Bibi R; Iffat W; Shakeel S; Muhammad IN
    Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1467-75. PubMed ID: 25176230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
    Battu SK; Repka MA; Majumdar S; Madhusudan RY
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
    Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
    Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.